Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence ; volume:22 ; number:1 ; day:27 ; month:5 ; year:2023 ; pages:1-12 ; date:12.2023
Cardiovascular diabetology ; 22, Heft 1 (27.5.2023), 1-12, 12.2023
- Creator
-
Schechter, Meir
Melzer Cohen, Cheli
Fishkin, Alisa
Rozenberg, Aliza
Yanuv, Ilan
Sehtman-Shachar, Dvora R.
Chodick, Gabriel
Clark, Alice
Abrahamsen, Trine J.
Lawson, Jack
Karasik, Avraham
Mosenzon, Ofri
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-023-01829-0
- URN
-
urn:nbn:de:101:1-2023091109030518404619
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schechter, Meir
- Melzer Cohen, Cheli
- Fishkin, Alisa
- Rozenberg, Aliza
- Yanuv, Ilan
- Sehtman-Shachar, Dvora R.
- Chodick, Gabriel
- Clark, Alice
- Abrahamsen, Trine J.
- Lawson, Jack
- Karasik, Avraham
- Mosenzon, Ofri
- SpringerLink (Online service)
Other Objects (12)
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin
Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Albuminuria
Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin
Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Albuminuria
Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin
Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Albuminuria